Emerging Therapeutic Implications of STK11 Mutation: Case Series.

Laderian B, Mundi P, Fojo T, E Bates S

Open source

DOI
10.1634/theoncologist.2019-0846
Published
2020 Sep
Container
The oncologist
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1634/theoncologist.2019-0846,
  title = {Emerging Therapeutic Implications of STK11 Mutation: Case Series.},
  author = {Laderian B and Mundi P and Fojo T and E Bates S},
  year = {2020},
  journal = {The oncologist},
  doi = {10.1634/theoncologist.2019-0846},
  url = {https://doi.org/10.1634/theoncologist.2019-0846}
}

RIS

TY  - JOUR
TI  - Emerging Therapeutic Implications of STK11 Mutation: Case Series.
AU  - Laderian B
AU  - Mundi P
AU  - Fojo T
AU  - E Bates S
PY  - 2020
JO  - The oncologist
DO  - 10.1634/theoncologist.2019-0846
UR  - https://doi.org/10.1634/theoncologist.2019-0846
ER  - 

APA

B, L., P, M., T, F., & S, E. B. (2020). Emerging Therapeutic Implications of STK11 Mutation: Case Series.. The oncologist. https://doi.org/10.1634/theoncologist.2019-0846

Source records